Finance

Lists
OTLC:OTCMKTS
Oncotelic Therapeutics Inc
0,021 USD
-0,95%
(-0,00020) 1D
9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLC...
Open
0,02 USD
High
0,02 USD
Low
0,02 USD
Mkt. cap
9,99 млн
Avg. vol.
336,56 миң
Volume
480,13 миң
P/E ratio
0,04
52-wk high
0,11 USD
52-wk low
0,02 USD
EPS
0,55 USD
Beta
-0,18
Shares outstanding
457,51 млн
No. of employees
41
Open
0,02 USD
High
0,02 USD
Low
0,02 USD
Mkt. cap
9,99 млн
Avg. vol.
336,56 миң
Volume
480,13 миң
P/E ratio
0,04
52-wk high
0,11 USD
52-wk low
0,02 USD
EPS
0,55 USD
Beta
-0,18
Shares outstanding
457,51 млн
No. of employees
41
News stories
From web sources and news partners
About Oncotelic Therapeutics Inc
CEO-
Employees41
Founded1988
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
250,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
426,00
3,34 миң
795,00
345,00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
490,55 миң
2,33 млн
1,85 млн
1,09 млн
Operating expense
490,97 миң
2,33 млн
1,85 млн
1,09 млн
Total operating expenses
490,97 миң
2,33 млн
1,85 млн
1,09 млн
Operating income
-490,97 миң
-2,33 млн
-1,85 млн
-843,56 миң
Other non operating income
-392,06 миң
326,43 миң
-90,08 миң
102,87 миң
EBT including unusual items
-1,11 млн
361,84 млн
-2,24 млн
341,01 миң
EBT excluding unusual items
-1,11 млн
-2,24 млн
-2,24 млн
-1,06 млн
Income tax expense
-
111,55 млн
-
-
Effective tax rate
-
30,83%
-
-
Other operating expenses
-
-
-
-
Net income
-1,05 млн
250,35 млн
-2,19 млн
388,15 миң
Net profit margin
-
-
-
155,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-231,34 миң
-242,57 миң
-295,81 миң
-318,29 миң
Net interest expenses
-231,34 миң
-242,57 миң
-295,81 миң
-318,29 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору